178 related articles for article (PubMed ID: 27812034)
1. Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes.
Hocum JD; Linde I; Rae DT; Collins CP; Matern LK; Trobridge GD
Sci Rep; 2016 Nov; 6():36610. PubMed ID: 27812034
[TBL] [Abstract][Full Text] [Related]
2. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
[TBL] [Abstract][Full Text] [Related]
3. A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.
Everson EM; Olzsko ME; Leap DJ; Hocum JD; Trobridge GD
Mol Ther Methods Clin Dev; 2016; 3():16048. PubMed ID: 27579335
[TBL] [Abstract][Full Text] [Related]
4. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Ohmine K; Li Y; Bauer TR; Hickstein DD; Russell DW
Hum Gene Ther; 2011 Feb; 22(2):217-24. PubMed ID: 20738155
[TBL] [Abstract][Full Text] [Related]
5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
6. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
7. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors.
Liu W; Backes P; Löchelt M
Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
9. Improved foamy virus vectors with minimal viral sequences.
Trobridge G; Josephson N; Vassilopoulos G; Mac J; Russell DW
Mol Ther; 2002 Sep; 6(3):321-8. PubMed ID: 12231167
[TBL] [Abstract][Full Text] [Related]
10. Helper-free foamy virus vectors.
Trobridge GD; Russell DW
Hum Gene Ther; 1998 Nov; 9(17):2517-25. PubMed ID: 9853518
[TBL] [Abstract][Full Text] [Related]
11. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
[TBL] [Abstract][Full Text] [Related]
14. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression by human foamy virus and potentials of foamy viral vectors.
Bodem J; Löchelt M; Yang P; Flügel RM
Stem Cells; 1997; 15 Suppl 1():141-7. PubMed ID: 9368334
[TBL] [Abstract][Full Text] [Related]
16. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
18. Transient foamy virus vector production by adenovirus vectors.
Russell RA; Vassaux G; Martin-Duque P; McClure MO
Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
[TBL] [Abstract][Full Text] [Related]
19. Lack of genotoxicity due to foamy virus vector integration in human iPSCs.
Deyle DR; Khan IF; Ren G; Russell DW
Gene Ther; 2013 Aug; 20(8):868-73. PubMed ID: 23388702
[TBL] [Abstract][Full Text] [Related]
20. Foamy virus vector integration sites in normal human cells.
Trobridge GD; Miller DG; Jacobs MA; Allen JM; Kiem HP; Kaul R; Russell DW
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1498-503. PubMed ID: 16428288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
